Palbociclib: first global approval

Drugs
Sohita Dhillon

Abstract

Palbociclib (Ibrance®) is an oral, reversible, selective, small-molecule inhibitor of cyclin-dependent kinases (CDK) 4 and CDK6 developed by Pfizer for the treatment of cancer. CDKs are important modulators of cell cycle entry and progression in response to growth signals, and inhibition of these kinases with palbociclib could enhance the activity of other anticancer drugs in tolerable regimens. Palbociclib, in combination with letrozole, was recently approved in the US for the first-line treatment of advanced breast cancer. Phase III development is underway worldwide investigating its use as first-line treatment in advanced breast cancer, as well as treatment of recurrent or advanced breast cancer and high-risk, early-stage breast cancer. A phase II trial is underway in the USA for non-small cell lung cancer under a US National Cancer Institute-funded research collaboration, and several phase I and II investigations are being conducted for various other solid tumour types and haematological malignancies. This article summarizes the milestones in the development of palbociclib leading to this first approval for use in postmenopausal women with estrogen-positive, human epidermal growth factor receptor (HER) 2-negative advanced b...Continue Reading

References

Jan 14, 2010·Breast Cancer Research : BCR·Robert L Sutherland, Elizabeth A Musgrove
Feb 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gottfried E KonecnyDennis J Slamon
Nov 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Keith T FlahertyGary K Schwartz
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A DicksonGary K Schwartz
May 7, 2013·Oncogene·Y J Choi, L Anders
May 28, 2013·Oncogene·C E S ComstockK E Knudsen
Nov 19, 2013·Urologic Oncology·Guru Sonpavde, Toni K Choueiri
May 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A Dickson
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela DeMichelePeter O'Dwyer

❮ Previous
Next ❯

Citations

Sep 1, 2015·The Journal of Urology·Anuja SatheRoman Nawroth
Jan 1, 2016·Trends in Pharmacological Sciences·M Lienhard Schmitz, Michael Kracht
Dec 10, 2015·Frontiers in Oncology·Lisette B W Schröder, Kerrie L McDonald
May 1, 2015·Journal of Translational Medicine·Maria FeldtSigne Borgquist
Jul 28, 2016·European Journal of Medicinal Chemistry·Peng WangYueqing Gu
Jul 13, 2016·Journal of Clinical Pharmacology·Yanke YuDiane Wang
Oct 4, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shuo Qie, J Alan Diehl
Jan 28, 2017·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Michaela NekardováKamil Paruch
Aug 23, 2018·Expert Opinion on Drug Metabolism & Toxicology·Antonella De LucaNicola Normanno
Aug 22, 2018·International Journal of Molecular Sciences·Cristian P MoiolaEva Colas
Apr 30, 2020·International Journal of Molecular Sciences·Jordan L KohlmeyerDawn E Quelle
Apr 30, 2017·Journal of Hematology & Oncology·Xichun HuMinhao Fan
Feb 14, 2018·International Journal of Molecular Medicine·Daguang WangJian Suo
Sep 12, 2018·Therapeutic Advances in Medical Oncology·Marc Thill, Marcus Schmidt
Aug 16, 2019·World Journal of Gastroenterology : WJG·Elena De MattiaGiuseppe Toffoli
Jul 27, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Eun Sik ChoiHo Sub Lee
Oct 9, 2020·Expert Opinion on Pharmacotherapy·Maximilian JulveMark P Lythgoe
Oct 11, 2020·Cancer Chemotherapy and Pharmacology·Yanke YuDiane Wang
Feb 5, 2021·Journal of Medicinal Chemistry·Rinky Raghuvanshi, Sandip B Bharate
Feb 19, 2021·Breast Cancer Research and Treatment·Lilibeth LancetaYoannis Imbert-Fernandez
Apr 28, 2021·European Journal of Medicinal Chemistry·Xiaoxia LiangBo Jing
May 11, 2021·Current Medical Research and Opinion·Gebra Cuyun CarterAndrew D Seidman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.